Psoricap cream 2 mg/g tube of 30 g

Instructions for Psoricap cream 2 mg/g tube 30 g

Composition

active ingredient: 1 g of cream contains zinc pyrithione 2 mg;

excipients: methylparaben (methyl parahydroxybenzoate) (E 218), butylhydroxytoluene (E 321), glycerol monostearate, polyglyceryl-3-methylglucose distearate, sucrose cocoate, methylglucose-10, stearyl alcohol, octyldodecanol, isopropyl palmitate, cyclomethicone, glycerin, citric acid monohydrate, purified water.

Dosage form

Cream.

Main physicochemical properties: white cream.

Pharmacotherapeutic group

Dermatological products. ATX code D11A X12.

Pharmacological properties

Pharmacodynamics

The drug has high antibacterial activity against a number of pathogenic microorganisms, such as streptococci, staphylococci, Pseudomonas aeruginosa and Escherichia coli, Proteus. The antifungal activity of the drug is especially pronounced against Pytyrosporum ovale and Pytyrosporum orbiculare, which cause inflammation and excessive peeling in psoriasis and other skin diseases. The drug acts against microorganisms located both on the surface and in the deep layers of the epidermis.

The special composition of the cream has hydrating properties, increases the antibacterial and antifungal effects of zinc pyrithione, helps eliminate burning and itching. Activated zinc pyrithione, which is in the cream, inhibits the pathological growth of cells of the surface layers of the skin, which are in a state of pathological hyperproliferation, eliminates excessive peeling in psoriasis and other skin diseases. The drug acts against microorganisms located both on the surface and in the deep layers of the epidermis.

Pharmacokinetics

When applied topically, zinc pyrithione is deposited in the superficial (epidermal) layers of the skin. Systemic absorption is slow. It is found in the blood in trace amounts.

Indication

Psoriasis, atopic dermatitis, seborrheic eczema in adults and children over 1 year of age, especially in widespread forms, as well as in itching, irritation, inflammation and increased dryness of the skin.

Contraindication

Hypersensitivity to one of the components of the drug.

Interaction with other medicinal products and other types of interactions

It is not recommended to use simultaneously with ointments and creams containing glucocorticosteroids.

Application features

Avoid contact with eyes. If the cream gets into your eyes, rinse them with plenty of running water and consult a doctor.

If the frequency of application of the cream increases, a mild, short-term local burning of the skin may occur.

The drug can be used during remission for maintenance therapy and relapse prevention, which allows you to quickly eliminate the manifest phase and accelerate clinical recovery. During remission, the cream is applied to the skin areas at the first signs of exacerbation of the disease.

The presence of methyl parahydroxybenzoate (E 218) in the composition may cause allergic reactions (possibly delayed).

The presence of butylhydroxytoluene (E 321) in the composition may cause local skin reactions (e.g. contact dermatitis) or irritation of the eyes and mucous membranes.

Ability to influence reaction speed when driving vehicles or other mechanisms

Does not affect.

Use during pregnancy or breastfeeding

During pregnancy or breastfeeding, the drug should be used only in cases where the benefit of use outweighs the potential risk to the fetus/child. The cream should not be applied to the nipples during breastfeeding.

Method of administration and doses

Lubricate the affected skin 2 times a day.

In psoriasis, the course of treatment is 1-1.5 months, in atopic dermatitis - 3-4 weeks, in other diseases the cream is prescribed until the symptoms disappear completely. In case of residual symptoms (hyperemia, dryness, peeling, pigmentation), continue to use the cream for 1-2 weeks.

Children

Do not use in children under 1 year of age.

Overdose

Possible increased manifestations of adverse reactions.

Adverse reactions

Hypersensitivity reactions are possible, including skin rashes, redness, itching, changes and a burning sensation at the site of application.

Expiration date

2 years.

Storage conditions

In the original packaging at a temperature not exceeding 25 ° C. Do not freeze. Keep out of the reach of children.

Packaging

30 g in a tube, 1 tube in a pack.

Vacation category

Without a prescription.

Producer

PJSC "Kyivmedpreparat".

Location of the manufacturer and its business address

01032, Ukraine, Kyiv, Saksaganskoho St., 139.